{
  "id": 9033710,
  "title": "AmCham-IMSS deal pledges US $44 million to bring clinical trials to Mexican public hospitals",
  "url": "https://urgent.news/2026/09/21/amcham-imss-deal-pledges-us-44-million-to-bring-clinical-trials-to",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-21T23:39:40.000Z",
  "source": {
    "name": "Mexico News Daily",
    "slug": "mexico-news-daily",
    "url": "https://mexiconewsdaily.com/business/amcham-imss-deal-pledges-us-44-million-to-bring-clinical-trials-to-mexican-public-hospitals/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The Mexican Social Security Institute (IMSS) and the American Chamber of Commerce of Mexico (AmCham) have signed a deal to invest over US $44 million in clinical trials within public hospitals from 2026 to 2030. The agreement, involving 11 pharmaceutical companies, aims to increase the number of clinical trials conducted in IMSS's hospital network, which boasts over 1,800 medical facilities serving approximately 70 million beneficiaries. IMSS Director General Zoé Robledo emphasized the unique capabilities of the public hospitals, stating that they offer at least as much as private hospitals, if not more. The initiative intends to translate research findings into improved patient care, particularly for high-prevalence or complex conditions such as diabetes, hypertension, cancer, kidney disorders, neurological diseases, and rare diseases.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}